Consistent quantitative gene product expression: #1. Automated identification of regenerating bone marrow cell populations using support vector machines

Por Voigt, Andrew P., Eidenschink Brodersen, Lisa, Pardo, Laura, Meshinchi, Soheil, Loken, Michael R.
Publicado no Cytometry A (2016)

Promyelocytic Leukemia with No Retinoic Acid Receptor Alpha Abnormality but with RUNX1T1 Insertion to Chromosome 7q: A Classification and Management Dilemma

Por Overholt, Kathleen, Guinipero, Terri L., Heerema, Nyla A., Loken, Michael R., Kahwash, Samir B.
Publicado no Case Rep Hematol (2015)

Lack of utility of chimerism studies obtained two to three months after myeloablative haematopoietic cell transplantation for acute lymphocytic leukaemia

Por Doney, Kristine C., Loken, Michael R., Bryant, Eileen M., Smith, Anajane G., Appelbaum, Frederick R.
Publicado em 2008

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome

Por Scott, Bart L., Wells, Denise A., Loken, Michael R., Myerson, David, Leisenring, Wendy M., Deeg, H. Joachim
Publicado em 2008

Consistent quantitative gene product expression: #3. Invariance with age

Por Loken, Michael, R., Voigt, Andrew P., Eidenschink Brodersen, Lisa, Fritschle, Wayne, Menssen, Andrew J., Wells, Denise A.
Publicado no Cytometry A (2016)

CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: Another key variant with potential impact on response to CD33-direc...

Por Papageorgiou, Ioannis, Loken, Michael R., Brodersen, Lisa Eidenschink, Gbadamosi, Mohammed, Uy, Geoffrey L., Meshinchi, Soheil, Lamba, Jatinder K.
Publicado no Leuk Lymphoma (2019)

Consistent quantitative gene product expression: #2. Antigen intensities on bone marrow cells are invariant between individuals

Por Loken, Michael R., Voigt, Andrew P., Eidenschink Brodersen, Lisa, Fritschle, Wayne, Menssen, Andrew J., Meshinchi, Soheil, Wells, Denise A.
Publicado no Cytometry A (2016)

CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients

Por Lamba, Jatinder, Voigt, Andrew P, Chauhan, Lata, Shin, Miyoung, Aplenc, Richard, Brodersen, Lisa Eidenschink, Gamis, Alan, Meshinchi, Soheil, Loken, Michael
Publicado no Leuk Lymphoma (2018)

Acute Myeloid Leukemia with RAM Immunophenotype: A Pediatric Case with Unusual Morphologic Features

Por Conces, Miriam, Abu-Arja, Rolla, Reed, Suzanne, Rangarajan, Hemalatha G., Guinipero, Terri L., Loken, Michael R., Brodersen, Lisa Eidenschink, Kahwash, Samir B.
Publicado no Hematol Rep (2017)

Gemtuzumab ozogamicin reduces relapse risk in FLT3/ITD acute myeloid leukemia: a report from the Children’s Oncology Group

Por Tarlock, Katherine, Alonzo, Todd A, Gerbing, Robert B, Raimondi, Susana C, Hirsch, Betsy, Sung, Lillian, Pollard, Jessica A, Aplenc, Richard, Loken, Michael, Gamis, Alan S, Meshinchi, Soheil
Publicado no Clin Cancer Res (2015)

CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children’s Oncology Group Trial AAML0531

Por Pollard, Jessica A., Loken, Michael, Gerbing, Robert B., Raimondi, Susana C., Hirsch, Betsy A., Aplenc, Richard, Bernstein, Irwin D., Gamis, Alan S., Alonzo, Todd A., Meshinchi, Soheil
Publicado no J Clin Oncol (2016)

CD33 expression and P-glycoprotein–mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin...

Por Walter, Roland B., Gooley, Ted A., van der Velden, Vincent H. J., Loken, Michael R., van Dongen, Jacques J. M., Flowers, David A., Bernstein, Irwin D., Appelbaum, Frederick R.
Publicado em 2007

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Por Loken, Michael R., Alonzo, Todd A., Pardo, Laura, Gerbing, Robert B., Raimondi, Susana C., Hirsch, Betsy A., Ho, Phoenix A., Franklin, Janet, Cooper, Todd M., Gamis, Alan S., Meshinchi, Soheil
Publicado em 2012

Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML

Por Pollard, Jessica A., Alonzo, Todd A., Loken, Michael, Gerbing, Robert B., Ho, Phoenix A., Bernstein, Irwin D., Raimondi, Susana C., Hirsch, Betsy, Franklin, Janet, Walter, Roland B., Gamis, Alan, Meshinchi, Soheil
Publicado em 2012

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Por Ostronoff, Fabiana, Othus, Megan, Gerbing, Robert B., Loken, Michael R., Raimondi, Susana C., Hirsch, Betsy A., Lange, Beverly J., Petersdorf, Stephen, Radich, Jerald, Appelbaum, Frederick R., Gamis, Alan S., Alonzo, Todd A., Meshinchi, Soheil
Publicado em 2014

miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group

Por Ramamurthy, Ranjani, Hughes, Maya, Morris, Valerie, Bolouri, Hamid, Gerbing, Robert B., Wang, Yi-Cheng, Loken, Michael R., Raimondi, Susana C., Hirsch, Betsy A., Gamis, Alan S., Oehler, Vivian G., Alonzo, Todd A., Meshinchi, Soheil
Publicado no Pediatr Blood Cancer (2016)

High Expression of the Very Late Antigen-4 Integrin Independently Predicts Reduced Risk of Relapse and Improved Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Child...

Por Walter, Roland B., Alonzo, Todd A., Gerbing, Robert B., Ho, Phoenix A., Smith, Franklin O., Raimondi, Susana C., Hirsch, Betsy A., Gamis, Alan S., Franklin, Janet L., Hurwitz, Craig A., Loken, Michael R., Meshinchi, Soheil
Publicado em 2010

ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial

Por Rafiee, Roya, Chauhan, Lata, Alonzo, Todd A., Wang, Yi-Cheng, Elmasry, Ahlam, Loken, Michael R., Pollard, Jessica, Aplenc, Richard, Raimondi, Susana, Hirsch, Betsy A., Bernstein, Irwin D., Gamis, Alan S., Meshinchi, Soheil, Lamba, Jatinder K.
Publicado no Blood Cancer J (2019)

CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children’s Oncology Group

Por Chauhan, Lata, Shin, Miyoung, Wang, Yi-Cheng, Loken, Michael, Pollard, Jessica, Aplenc, Richard, Hirsch, Betsy A., Raimondi, Susana, Ries, Rhonda E., Bernstein, Irwin D., Gamis, Alan S., Alonzo, Todd A., Meshinchi, Soheil, Lamba, Jatinder K.
Publicado no JCO Precis Oncol (2019)

Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group

Por Aplenc, Richard, Meshinchi, Soheil, Sung, Lillian, Alonzo, Todd, Choi, John, Fisher, Brian, Gerbing, Robert, Hirsch, Betsy, Horton, Terzah, Kahwash, Samir, Levine, John, Loken, Michael, Brodersen, Lisa, Pollard, Jessica, Raimondi, Susana, Kolb, Edward Anders, Gamis, Alan
Publicado no Haematologica (2020)